Valtteri Kaasinen
MD, PhD, Professor of Neurology
valtteri.kaasinen@utu.fi |
Clinical Neurology; Movement Disorders; Parkinson's disease; Addictions; Neurotransmitters; Neuroimaging; PET; SPECT; Dopamine System
Movement disorders, neurotransmitters and addictions
Dr. Kaasinen is Professor of Neurology at the University of Turku, and Chief Physician at Neurocenter of Turku University Hospital.
He was appointed as Adjuct Professor of Neurology in 2011, received special competence in medical education in 2016, and was appointed as full Professor of Neurology in 2021.
Dr. Kaasinen is a clinical neurologist and a movement disorder specialist who received his medical degree from the University of Turku in 1996. This was followed by a PhD focusing on brain dopamine PET imaging of Parkinson's disease in 2000. He did his postdoctoral training in 2003-2004 in the University of Groningen, The Netherlands.
Since 2004, he has led a research group that focuses on function brain PET and SPECT neurotransmitter imaging in Parkinson's disease, other movement disorders and behavioral addictions. His group is involved in several project that aim to improve diagnostics and treatment of neurological movement disorders.
Main focus of research is brain function and dysfunction in relation to neurotransmitters, addictions and movement disorders.
Dr. Kaasinen has been involved in curriculum planning and implementation of neurology courses since 2013. He is a personal teacher mentor for medical students and has supervised of several PhD students.
- Uutta tietoa Parkinsonin taudin synnyn ja tupakoinnin välisistä yhteyksistä (2020)
- Duodecim
- Wilson's Disease in Finland: A Nationwide Population‐Based Study (2020)
- Movement Disorders
- Altered orbitofrontal sulcogyral patterns in gambling disorder: a multicenter study (2019)
- Translational Psychiatry
- Bupropion Causes Misdiagnosis in Brain Dopamine Transporter Imaging for Parkinsonism (2019)
- Clinical Neuropharmacology
- Burden of non-motor symptoms in unclear parkinsonism and tremor: A study with [I-123]FP-CIT SPECT (2019)
- Journal of the Neurological Sciences
- Gender-dependent improvement in the survival of Parkinson’s disease patients in Finland (2019)
- Movement Disorders
- Huntingtonin tauti (2019)
- Duodecim
- Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT (2019)
- Journal of Neurology
- Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects (2019)
- Neuropsychopharmacology
- Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System (2019)
- Alzheimer's & dementia: diagnosis, assessment & disease monitoring
- No Link Between Striatal Dopaminergic Axons and Dopamine Transporter Imagingin Parkinson’s Disease (2019)
- Movement Disorders
- Presynaptic Striatal Dopaminergic Function in Atypical Parkinsonism: A Metaanalysis of Imaging Studies (2019)
- Journal of Nuclear Medicine
- Progressive dopaminergic defect in a patient with primary progressive multiple sclerosis (2019)
- Multiple Sclerosis and Related Disorders
- Reply to: The time delay between in vivo imaging and postmortem data poses a caveat on "no link" findings (2019)
- Movement Disorders
- Särö-X-esimutaatio-oireyhtymä (FXTAS) - magneettikuvauksesta apua diagnosointiin (2019)
- Duodecim
- Season of death and nigral neuronal density in a high-latitude region (2019)
- Neuropathology and Applied Neurobiology
- Toiminnallisten liikehäiriöiden työryhmä avuksi ongelmatapauksiin (2019)
- Lääkärilehti
- Aikuisiällä alkaneen Huntingtonin taudin lääkehoito Suomessa (2018)
- Lääkärilehti
- Aivojen hermovälittäjäaineiden isotooppitutkimukset (2018) Kliinisen fysiologian ja isotooppilääketieteen perusteet Valtteri Kaasinen, Marko Seppänen
- Binge eating disorder and morbid obesity are associated with lowered mu-opioid receptor availability in the brain (2018)
- Psychiatry Research: Neuroimaging